BVS

9.8800.70%
MM

Michelle McMurry-Heath

Independent Director

Dr. Michelle McMurry-Heath, MD, Ph.D., serves as an Independent Director at Revvity, Inc. (formerly known as PerkinElmer, Inc.) since July 22, 2022. She is Director at Nuclear Threat Initiative, Inc since April 2022. She is Independent Director at Bioventus Inc. since January 1, 2022. She has served in dynamic policy, regulatory, commercial health care and advocacy roles. She is a medical doctor and immunologist whose career spans government, the pharmaceutical industry and biotechnology. Dr. McMurry-Heath served as President and Chief Operating Officer of the Biotechnology Innovation Organization from 2020 to 2022. She served as President and Chief Executive Officer of Biotechnology Innovation Organization from 2020 to 2022. Dr. McMurryHealth was previously with Johnson & Johnson (J&J) from 2014 to 2020, where she served as Global Head of Evidence Generation for Medical Device Companies and then Vice President of Global External Innovation and Global Leader for Regulatory Sciences. Prior to her time at J&J, Dr. McMurry-Heath was a key science policy leader in government, conducting a comprehensive analysis of the National Science Foundation's policies, programs and personnel. President Obama then named her associate science director of the FDA's Center for Devices and Radiological Health where she served from 2010 to 2014. She also was founding director of the Aspen Institute's Health, Biomedical Science and Society Policy Program. She previously served as Johnson & Johnson's Vice President, External Innovation, Global Leader for Regulatory Science and Executive Director of Scientific Partnerships for JLABS@DC. She joined J&J in 2014, first as its Worldwide Vice President and Global Head, Regulatory Affairs and later adding responsibilities for the company's International Clinical Evidence and Strategic Operations. Prior to that, she served as Associate Center Director for Science, Center for Devices and Radiological Health at the U.S Food and Drug Administration. She spent 12 years working at the research bench before taking policy and leadership roles in government and industry. From 2005 to 2010, She was Director Health, Biomedical Science and Society Policy Program at the Aspen Institute. She began her career as a Senior Policy Advisor for Senator Joseph Lieberman for Health, Social and Biomedical Innovation Policy from 2001 to 2004. She later served as a Robert Wood Johnson Health and Society Scholar at the University of California, San Francisco and Berkeley from 2004 to 2005 and a Mcarthur Fellow, Global Health for the Council on Foreign Relations from 2004 to 2006. Dr. McMurray-Heath received her M.D./Ph.D. in Immunology from Duke University's Medical Scientist Training Program, becoming the first African American to graduate from the prestigious program and her AB in Biochemistry from Harvard University.

Positions